Nanjing Keen Lisi Biopharmaceutical
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- Undisclosed
Investors
- 3
Who invested in Nanjing Keen Lisi Biopharmaceutical
3 investors across 1 round
See all investors in Nanjing Keen Lisi Biopharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 7, 2023
Amount
Undisclosed
Investors
Questions about Nanjing Keen Lisi Biopharmaceutical
Who invested in Nanjing Keen Lisi Biopharmaceutical?
Nanjing Keen Lisi Biopharmaceutical has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Keen Lisi Biopharmaceutical raised?
Nanjing Keen Lisi Biopharmaceutical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanjing Keen Lisi Biopharmaceutical last raise money?
Nanjing Keen Lisi Biopharmaceutical's most recent round on record is a Series A, in Dec 2023.
What does Nanjing Keen Lisi Biopharmaceutical do?
Nanjing Keen Lisi Biopharmaceutical is a biotechnology company.
Where is Nanjing Keen Lisi Biopharmaceutical headquartered?
Nanjing Keen Lisi Biopharmaceutical is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Keen Lisi Biopharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nanjing Keen Lisi Biopharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nanjing Keen Lisi Biopharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.